Applied Biosystems said this week in a document filed with the US Securities and Exchange Commission that it has accepted the retirements of six board members effective immediately following the completion of its merger with Invitrogen.
The members are Robert Hayes; Elaine Mardis; Theodore Martin; Carolyn Slayman; James Tobin; and Tony White.
The $6.7 billion merger is expected to close this week. The combined company will be called Life Technologies.
MDS this week appointed James MacDonald chairman of its board effective immediately. He replaces John Mayberry who resigned from the board citing other business obligations.
MacDonald has been on MDS’ board since 2005 and is a member of its audit committee. He is chairman and managing partner of Enterprise Capital Management. Prior to 1997, he was deputy chairman of Scotia McLeod. He is also a director of Cinram International Income Fund, Cymbria, Manitoba Telecom Services, and Superior Plus, and is the non-executive chairman of Cormark Securities.
Advanced Proteome Therapeutics this week announced Robert Bender and Russell Phares resigned from its board on Oct. 11.
No reasons were given for their departure.
Also effective Oct. 17, Jean Bellin became the chairman of APT’s audit committee. Bellin is president of Metagenics. Before that he was CEO of Mountain View Pharmaceuticals. He currently is on the board of KV Pharmaceutical.